We’re pleased to share that FIZE Medical was recently featured in Calcalist Tech (CTech) following the first close of our $20 million Series B financing round, co-led by Asahi Kasei Medical and Rapha Capital Management.
The article highlights FIZE Medical’s continued expansion in the U.S., Europe, Israel and Japan, as well as the development of FIZE Optima™, our next-generation platform designed to use continuous physiological data to support more predictive and data-driven fluid management in critically ill patients.
It also covers the expansion of our strategic relationship with Asahi Kasei Medical, which serves as FIZE’s exclusive distributor in Japan and is expanding its role into Europe.
Read HERE the full Calcalist Tech article.
